Communication Interface Technologies v. CVS Health: Voluntary Dismissal in Mobile App Patent Dispute
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | Communication Interface Technologies, LLC v. CVS Health Corp. |
| Case Number | 4:24-cv-00166 |
| Court | Texas Eastern District Court |
| Duration | Feb 2024 – Apr 2024 45 days |
| Outcome | Plaintiff Voluntary Dismissal (Without Prejudice) |
| Patents at Issue | |
| Accused Products | CVS App |
Case Overview
The Parties
⚖️ Plaintiff
A patent assertion entity (PAE) with an IP portfolio focused on communication interface and network connectivity technologies.
🛡️ Defendant
One of the largest healthcare companies in the U.S., operating retail pharmacies, PBM services, and a major consumer-facing mobile application.
Patents at Issue
This case involved three U.S. patents asserted by Communication Interface Technologies, LLC, covering critical aspects of network communication essential to modern mobile application functionality.
- • US6574239B1 — Covers foundational communication interface technology in network data transmission.
- • US8291010B2 — Directed to methods and systems for communication interface management.
- • US8266296B2 — Relates to communication interface protocols and data exchange architectures.
Developing a mobile application with communication features?
Check if your mobile app might infringe these or related patents before launch.
The Verdict & Legal Analysis
Outcome
The case concluded via a Notice of Voluntary Dismissal Without Prejudice filed by Communication Interface Technologies, LLC pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i). No damages were awarded, and no injunctive relief was granted or denied. Each party was ordered to bear its own costs, expenses, and attorneys’ fees — a standard provision in pre-answer dismissals.
Key Legal Issues
Because the dismissal preceded any answer, claim construction, or dispositive motion practice, no judicial findings were made regarding patent validity, infringement, or claim construction of any asserted patent terms. The 45-day duration strongly suggests that the plaintiff achieved its primary objective (initiating licensing negotiations) or that defense counsel mounted sufficient pre-answer pressure (e.g., through informal invalidity challenges or IPR threat letters), making continued litigation unviable for the plaintiff. The dismissal being “without prejudice” means the plaintiff retains the right to refile these claims in the future.
Freedom to Operate (FTO) Analysis
This case highlights critical IP risks for mobile applications with network communication functionality. Choose your next step:
📋 Understand This Case’s Implications
Learn about the specific risks and insights from this voluntary dismissal.
- Explore Communication Interface patent landscape
- Identify active NPEs in mobile app technology
- Understand FRCP 41 implications for patent litigation
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your mobile application or technology.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Mobile applications with network communication functionality
3 Asserted Patents
In communication interface domain
Strategic Defense Value
Early defense action can lead to quick dismissal
✅ Key Takeaways
FRCP 41(a)(1)(A)(i) dismissals without prejudice in NPE cases require ongoing docket monitoring — refiling risk is real.
Search related case law →No merits ruling means US6574239B1, US8291010B2, and US8266296B2 remain valid and unlitigated on the merits.
Explore patents in Eureka →East Texas venue continues to attract communication interface patent assertions despite evolving venue jurisprudence post-*TC Heartland*.
Analyze venue trends →Frequently Asked Questions
Three U.S. patents: US6574239B1, US8291010B2, and US8266296B2, all covering communication interface and network data transmission technologies.
Plaintiff filed a voluntary dismissal without prejudice under Federal Rule of Civil Procedure 41(a)(1)(A)(i) before CVS Health filed any answer, closing the case in 45 days with no merits determination.
Yes. The without-prejudice dismissal preserves the plaintiff’s right to refile, subject to applicable statutes of limitations.
Ready to Strengthen Your Patent Strategy?
Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.
References
- PACER — Federal Court Records System (Case 4:24-cv-00166)
- USPTO Patent Full-Text Database — Patents US6574239B1, US8291010B2, US8266296B2
- Cornell Legal Information Institute — Federal Rule of Civil Procedure 41(a)(1)(A)(i)
- PatSnap — IP Intelligence Solutions for Law Firms
This article is for informational purposes only and does not constitute legal advice. All case information is drawn from publicly available court records. For platform capabilities, visit PatSnap.